India: Anomalies Of Section 3(1) Of The Indian Competition Act

The first ever order under section 3(1) of the Competition Act, 2002 (Act), Ramakant Kini v. Dr. L.H. Hiranandani Hospital, Powai, Mumbai (Hiranandani),1 has witnessed its fair share of controversy since the Competition Commission of India (Commission/ CCI) laid the precedence for a standalone applicability of section 3(1) and observed that, "Section 3(3) and section 3(4) are expansion of section 3(1) but are not exhaustive of the scope of section 3(1)..... scope of section 3(1) is independent of provision of section 3(3) & 3(4)".2

It took almost three years for the Commission to put section 3(1) into effect, despite the repeated acceptance by one of its ex-members, Mr. Rajender Prasad, who passed various dissent orders acknowledging the standalone application of section 3(1). In Neeraj Malhotra v. Deutsche Post Bank Home Finance,3 the member noted that if an enterprise deals with an individual by entering into an agreement which causes an appreciable adverse effect on competition (AAEC) in India would be hit by Sections 3(1) and 3(2) of the Act. Similarly, in Savitri Leasing and Finance Ltd v. Punjab National Bank and Others,4 a pre-penalty payment clause levied by the banks on the consumers for switching their loans to another bank, was held as anti-competitive and violative of 3(1). It was observed that, being an end-consumer agreement, the said section cannot fall under section 3(4), but nevertheless reduced efficiencies, prevented new entrants and exploited consumers and was therefore caught under 3(1).5

What remains surprising is the Commission's reluctance to pass a single order after Hiranandani, invoking the standalone applicability of the provision. Even though the Commission had bare minimal reasons to assign for its independent enforcement,6 the possibility of certain agreements not falling under horizontal [S. 3(3)] or vertical categories [S. 3(4)] cannot be disregarded. Agreements between entities forming part of completely distinct supply/ production chains may not fall under sections 3(3) or 3(4) of Act, yet lead to anti-competitive effects.


Section 3(1) raises the question of whether there can, in fact, be agreements which do not fall under either the 3(3) horizontal or 3(4) vertical variety. For instance even in Hiranandani, the agreement was examined vis-a-vis the hospital, however, the same could have been considered as an exclusive supply agreement from the stem cell bank's perspective (considering that the hospital's are the a crucial part of the bank's supply/ production chain and without which the banks cannot operate).7 The most apt order to highlight the inconsistencies between Commission's own orders is Shri Sonam Sharma v. Apple Inc. USA & Ors.,8 wherein the Commission had categorically noted that, "The present case involves a distribution / sales arrangement between Apple and Airtel / Vodafone is a case of 'contractual tying' wherein the handset manufacturer and service provider have joined hands to offer a packaged product to a customer."9 The nature of the agreement between Apple and Vodafone / Airtel, was similar to the agreement entered into between Hiranandani and Cryobanks. Moreover, Apple (handset manufacturer) and Vodaphone/ Airtel (service provide) dealt with completely different products / services and therefore, formed part of different supply /production chains. Yet, the Commission considered the same as a tie-in arrangement falling under Section 3(4) rather than 3(1), and thereafter, scrutinized the AAEC.10 In the present case the issue of a consumer, interested in buying an iPhone, being tied to one of the two mobile networks i.e. Airtel or Vodafone, is comparable to the factual matrix in Hiranandani; yet Commission chose to enforce section 3(1) independently. Based on its own observations in the present case, there seems no justification behind considering the agreement in Hiranandani under section 3(1).

The Commission's commitment to the standalone applicability of section 3(1) also appears fickle considering its most recent order in Financial Software and Systems Private Limited v. M/s ACI Worldwide Solutions Private Limited & Ors.,11 wherein the Commission observed that the agreements between ACI and ACI banks cannot be caught under section 3(4) of the Act since ACI banks are the purchasers of ACI software and hence, they do not form part of the production chain as required for Section 3(4) to apply. After setting the precedent itself, it is unexpected of the Commission to be unwilling and hesitant in invoking section 3(1) in matters of the said nature.

Similarly, in Jeetender Gupta v. BMW India Ltd and Anr,12 the informant alleged issues of bundling of the sale of BMW cars with a specialized insurance policy by BMW India Ltd., which not only allegedly affected the consumer interest by precluding them from considering alternate insurance policy but also led to denial of market access to other insurance companies. Although, the allegation was that of abuse of dominance, nothing precluded the Commission from considering a similar set of facts under either Section 3(4) (being an exclusive tie-up) or the omnibus section 3(1) of the Act. Similarly, in Consumers Guidance Society v. Hindustan Coca Cola Beverages Pvt. Ltd. (HCC) and INOX Leisure Pvt. Ltd. (Inox),13 the informant contested the exclusive agreement between Inox and HCC under section 3(4), whereby, HCC was appointed as 'preferred beverage provider' for Inox, resulting in complete foreclosure of competition due for the competitors and inflated prices of goods for the consumers. The Commission yet again dismissed the complaint due to the lack of a showing of dominance by Inox and HCC.

Relevant market and AAEC

Hiranandani also raises certain other questions which remain unanswered. A reading of the section clearly suggests that, an AAEC analysis is crucial for its applicability. Consumer harm alone cannot be sufficient to hold an agreement void under section 3(2) of the Act.14 The Commission did not delineate the relevant market15 in that case for an effective AAEC analysis and noted that such exclusive arrangements do not accrue any benefit to the consumer and are rather at the cost of consumer and the competition in stem cell service industry is bound to be hindered. The Commission's stance that delineation of relevant market is not necessary for the purposes of section 3(3)16 seems to have a seeping effect on section 3(1) as well, which may destroy the very purpose of and AAEC analysis and section 19(3). The Commission, in Hiranandani observed that for the purpose of section 3, it need not identify the relevant market, but nevertheless noted that it is the market of stem cell banking in which competition was being adversely affected. While stating the same, the Commission, did not make an effort to delineate the relevant product or geographic markets separately, let alone the factors prescribed under sections 19 of the Act. The crux of section 3(1) is causation or likelihood of adverse impact within a particular market; if the said limb is severed from the section, a standalone enforcement of the section can only be unwarranted and unreasonable. With this reluctance of the Commission to delineate the relevant market in section 3 cases, it is hard to envision its assessment under section 3(1) and the basis of holding an agreement anti-competitive.


Finally, the levy of penalty has further added to the anomalies appended to section 3(1). In Hiranandani, even when the agreement entered into between the hospital and the stem cell bank was held to be anti-competitive and moreover, the stem cell banking market was observed to be affected, the Commission only penalized the hospital. It is difficult to comprehend the reasons behind doing the same and the Commission has not assigned reasons behind the said approach, failing which, the question of penalty remains a mystery until the Commission passes another order under section 3(1). Unfortunately, there hasn't been a single order penalizing an entity based on the standalone application of section 3(4) alone, to draw a comparison or lay reference.


The question regarding the standalone applicability of Section 3(1) thus still remains unsettled and open-ended. It will be definitely worthwhile to witness Commission's approach and how the unaccompanied implementation of section 3(1) can help assessing agreements / conducts not caught under sections 3(3), 3(4) and 4. The provision definitely has over-arching effect and can allow the Commission to take cognizance of any agreement entered into between two entities, but the issues of delineation of relevant market, assessment of AAEC within the relevant market, consideration factors under section 19(3), penalizing all delinquent entities to the agreement, ensuring that the agreement does not fall under 3(4) etc., are hitherto unresolved.


1. Ramakant Kini v. Dr. L.H. Hiranandani Hospital, Powai, Mumbai, Case No. 39 of 2012, order dated 05 February, 2014

2. Ibid at ¶ 11.

2. Case No. 5 of 2009, order dated 02 December, 2010

4. Case No. 45 of 2011, order dated 12 October, 2011

5. In V. Ramachandra Reddy and Others v. M/s HDFC Bank Ltd. and M/s ICICI Bank Ltd., Case Nos.7 of 28, 25 of 28, 8 of 28, 9 of 28 & 10 of 28, order dated 31 May, 2011, and M/s Metalrod Ltd. v. M/s Religare Finvest Ltd, Case No. 28 of 2010, order dated 23 May, 2011, similar allegations were levied against HSBC bank and Religare and it was observed that an agreement between the banks and consumers are hit by section 3(1) of the Act since they lead to an AAEC within India.

6. Ibid at ¶ 11, "There can be various kinds of agreements among enterprises which may fall under section 3(1) including agreements which are against the interests of consumers, affect freedom of trade and cause or are likely to cause appreciable adverse effect on competition in India....It is also evident from a reading of section 19(1) and section 33 that both these sections also talk of violation of section 3(1) and not section 3(3) & 3(4). This makes it abundantly clear that scope of section 3(1) is independent of provision of section 3(3) & 3(4)."

7. The agreement stipulated that hospital will offer exclusively Cryobanks International India stem cell banking services for its patients for a period for one year.

8. Case No. 24 of 2011, order dated 19 March, 2013

9. Ibid at ¶ 70

10. The Commission noted at ¶ 66 "A tying arrangement occurs when..... a firm selling products X and Y makes the purchase of product X conditional to the purchase of product Y. Product Y can be purchased freely on the market, but product X can only be purchased together with product Y." – Commission uses the word sale as opposed to manufacture, which negates the requirement of existence of the same supply/purchase chain, since, one entity may be selling two distinct products, whether or not both are manufactured by the said entity.

11. Case No. 52 of 2013, order dated 13 January, 2015

12. Case No. 104 of 2013, order dated 28 February, 2014

13. Case No. UTPE 99 of 2009, order dated 23 May, 2011

14. Section 19 of the Act requires consideration of factors such as creation of barriers to new entrants in the market, driving existing competitors out of the market, foreclosure of competition by hindering entry into the market etc., while assessing AAEC.

15. Relevant market was delineated for the purposes of Section 4 analysis only and the Commission noted that "It must be kept in mind that for the purpose of section 3, the Commission is not required to identify the relevant market...." (¶ 25 of the Hiranandani Order)

16. In Builders Association of India v. Cement Manufacturers' Association and Others, Case No. 29 of 2010, order dated 20 June, 2012, the Commission observed that "The Commission observes that there is no requirement under the provisions of section 3(1) and section 3(3) of the Act as also under section 19(3) to determine and construct a relevant market, although that remains sine-qua-non for the determination of contravention under the provisions of section 4 of the Act. Sections 3(1) and 3(3) are concerned with effect of anti-competitive agreements on markets in India...", ¶ 6.5.44

Tripti Malhotra is an Associate in the Competition Law Practice Group at Luthra & Luthra. After graduating from Symbiosis Law School, Pune in 2013 with a degree in B.B.A.,LL.B. (Hons.), she has handled diverse assignments and worked extensively for matters involving intricate competition law issues across all sectors including real estate, telecommunication infrastructure, tyre industry, cement industry, auto parts, construction equipment, sugar, as well as professional bodies such as the Chartered Accountants Institute etc.. She has handled complex cases of abuse of dominance, cartel investigations, as well as merger filings. She has been part of various competition compliance programmes for several multi-national conglomerates and Indian companies. She is representing clients before various fori including the Competition Commission of India (CCI), the Competition Appellate Tribunal, the Delhi High Court, and the Supreme Court. She has the distinction of participating in the first dawn raid by the CCI, successfully challenged before the High Court.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions